MYD88 and metabolic dysfunction-associated steatohepatitis: In conclusion, administration of myricetin attenuated hepatocyte injury and death, inflammation, and fibrogenesis in the CDAHFD-diet-induced NASH model through regulating polarization of macrophages in livers via TREM-1-TLR2/4-MyD88 signaling pathways.